RecruitingNot ApplicableNCT05112705

Diagnosing Deep-vein Thrombosis Early in Critically Ill Patients

Diagnosing Deep-vein Thrombosis Early in Critically Ill Patients (DETECT) Trial

Sponsor

King Abdullah International Medical Research Center

Enrollment

1,800 participants

Start Date

Mar 21, 2023

Study Type

INTERVENTIONAL

Conditions

Pulmonary Embolism Deep Vein Thrombosis

Summary

The DETECT randomized controlled trial addresses the question of whether surveillance ultrasound in critically ill patients by facilitating DVT detection reduces the incidence of PE and lowers all-cause 90-day mortality. The primary outcome is 90-day all-cause mortality.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Proximal lower limb ultrasound for people with deep vein thrombosis and pulmonary embolism. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.